T he technological imperative is changing the field of electrophysiology, and we are currently at a crossroads in complex ablation. The rapid emergence of electroanatomic mapping with multielectrode catheters was spawned out of both intellectual necessity (desire for mechanistic insights into arrhythmias) and clinical necessity (to expedite mapping time). During the 1980s, mapping with single-point catheters and multielectrode catheters was proven to be useful for arrhythmia substrate characterization in the intraoperative setting. 1, 2 In 1999, single-point catheter-based mapping was first validated using the CARTO system by Callans et al 3 in a porcine model of myocardial infarction. This validation was performed with 75 endocardial points, and the electroanatomic map obviated the reliance on fluoroscopic substrate-based ablation within regions of low voltage and quickly became the central platform for scar-based ventricular tachycardia (VT) procedures. Seventeen years later, the validation of an automated mapping system (Rhythmia; Boston Scientific, Natick, MA) with microelectrodes on a miniature basket catheter was demonstrated in a porcine model, with an average of >8000 mapping points. 4, 5 It is a foregone conclusion that as a field, we are already on the road to higher resolution with multielectrode catheters becoming the new mainstay for mapping of complex arrhythmias. Several questions require further examination as the optimal role of multielectrode mapping remains to be fully defined (1) How did we get here? (2) What are the obstacles that lie ahead? (3) Where is our ultimate destination?
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How Did We Get Here?
Multielectrode catheters have been implemented routinely for rapid diagnosis for supraventricular tachycardias using coronary sinus activation and in the anterolateral right atrium for cavotricuspid isthmus flutter since the early 1990s. 6 However, simultaneous acquisition of this electrical information into electroanatomic mapping systems to detail scar did not gain popularity throughout the 1990s to early 2000s, as the accuracy of these points remained in question because of variable tissue contact. A prevalent view was a healthy skepticism for the accuracy of voltage information because of the inability to insure adequate contact with multiple electrodes.
The impedance-based electrofield system (NAVX; St. Jude Medical, Minneapolis, MN) was the first commercial mapping system that allowed for simultaneous voltage and activation acquisition from any catheter, regardless of model, make, configuration, and electrode number. Patel et al 7 first demonstrated the use with a 5-splined catheter (Pentaray; Biosense Webster, Diamond Bar, CA) to rapidly map left atrial flutters in the inaugural issue of this journal. In 2009, we began a series of experiments at University of California at Los Angeles to directly compare the accuracy of single-point acquisition with multielectrode mapping of ventricular scar in a porcine infarct model with extrapolation to human cases. To our knowledge, this was the first validation of multielectrode mapping in the epicardium and endocardium of left ventricle, where ≈3-fold increases in mapping density could be achieved in the same time period using a duodecapolar catheter. 8, 9 In 2014, multielectrode mapping was incorporated in the magnetically based mapping system (CARTO MEMS; Biosense Webster). This signified the adoption of the undeniable trend in highdensity mapping as an initial multielectrode catheter failed to gain clinical popularity (Qwikmap; Biosense Webster). In 2012, a novel spatiotemporal mapping system (Topera; Abbott Medical, Chicago, IL) using a 64-electrode basket catheter for biatrial panoramic mapping of atrial fibrillation reinvigorated the field with new focus aimed to investigate the electrophysiological mechanisms of fibrillatory conduction.
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Obstacles Ahead
Simultaneous multielectrode mapping introduces an entirely new set of challenges from a purist perspective. Although a large number of points can be acquired quickly and the aesthetic appearance of electroanatomic maps is improved as the result of less interpolation, the accuracy of these points needs to be verified with respect to electrogram integrity and annotation. Even with the most sophisticated automated mapping technology, it is likely that human input will always be needed to over-read electroanatomic mapping data because of noise, artifacts, and near-field versus far-field determination. Currently, ripple mapping displays are the only commercially available system that allows for the annotation of multiple near-field electrogram components at a single site. 11 Manual correction of a fully automated map can be paradoxically time-consuming if there are an overabundance of neighboring points around an inaccurate annotation.
Emergence of Multielectrode Mapping
Electrogram voltages are dependent on the electrode size, spacing, and the angle of the incident wavefront to the catheter. 12 The universally implemented 1.5-mV threshold for ventricular scar, 3, 13 derived from a standard ablation catheter, is unlikely to be consistent across the new assortment of catheters that are available in the electrophysiologists toolbox for multielectrode mapping (Figure ; Table) . For this reason, individualized validation is required, and comparative studies are needed. In real-world practice, mapping points acquired from a multipolar catheter and single-point catheter are frequently combined on the same map, and this may result in inaccurate depictions of complex scar or activation patterns.
In this context, Tschabrunn et al 14 present an original article comparing myocardial scar characterization in a swine model with a multielectrode catheter (Pentaray) with a standard ablation catheter. By examining the normal distribution in 3 healthy swine, the authors report similar statistical 95% thresholds with a Pentaray compared with ablation catheter (1.48 versus 1.61 mV), consistent with the widely implemented 1.5-mV value. By using a left anterior descending occlusionreperfusion infarct model (n=11), the authors report that when using a 1.5-mV threshold, scar areas were 22% smaller when mapped with a multielectrode catheter with 1-mm electrode size. Furthermore, dense scar regions of <0.5 mV were 47% smaller when using a Pentaray compared with an ablation catheter. Greater tissue heterogeneity within scar was observed as the authors localized reentrant circuits to mixed scar areas with relatively preserved voltage channels with histological confirmation. Pacing thresholds were lower during pacing within scar from smaller electrodes, suggesting a greater ability to capture viable near-field tissue within dense scar.
On the surface, the take-home message from this work may be that smaller electrode catheters increase the sensitivity to identify normal surviving bundles of myocardium during sinus rhythm and VT, relative to large tipped catheters. Although this may indeed the cases, there are several variables that are present in this well-designed study that may further contribute to these findings. Beyond electrode size, interelectrode spacing is different, and even further confounded by whether the spacing is calculated as edge-to-edge (1 mm ThermoCool ST versus 2 mm Pentaray) or center-to-center (3.25 ThermoCool ST versus 3.0 mm Pentaray). The density of mapping achieved with multielectrode platform was over double the number of points sampled with the ablation catheter (986 versus 462; P<0.01). It is not clear whether the differences observed would be similar if the density of single-point acquisition was increased, to decrease interpolated regions of low voltage. Finally, the The authors should be congratulated on the rigor in which they conducted this elegant animal study, incorporating imaging, histology, and activation mapping of VT. This work convincingly demonstrates that the depiction of complex scar substrates is inherently influenced by mapping density and electrode type. Additional studies are necessary to determine whether voltage thresholds should be individually tailored. Because of these inherent variables in voltage mapping, methods that incorporate functional information related to scar and channel propagation may be promising. 15 Tschabrunn et al 14 also show that within regions of tissue heterogeneity, a strict voltage cutoff to define scar is not reflective of scar biology. Berte et al 16 recently published a similar comparison of multielectrode versus a Navistar catheter (4-mm tip, 3.5 center-to-center) by mapping in an ovine model (n=4) and 9 patients with scar-related VT. With >4× the mapping density achieved with a Pentaray, the authors reported that scar areas were larger with small electrodes because of less farfield sensing. Although these findings are in contrast with the present study, substrate variability accounts for some of these differences. More importantly, the data may be more similar if the scar area calculations used in these studies were purely based on the 95% statistical threshold derived from the respective model. Furthermore, differences in scar area are likely if a remap is performed with the same catheter and density.
Where Is Our Final Destination?
Like with television technology, there is likely to a limit to higher resolution where appreciable differences may not be discernible to the human eye. In clinical medicine, this limit may be the line where there is not measurable difference in patient outcomes. For example, the creation of a map for typical atrial flutter or a focal arrhythmia with >1000 points will likely not translate into greater freedom from clinical recurrence. With mapping density, it may be reasonable to hypothesize that increasing density from 100 to 500 points may be clinically impactful, but the utility of adding another 1000 points to a 5000 point map may have diminishing returns. Activation mapping of focal and reentrant rhythms is frequently localized to a small region of interest, obviating the need for high-density mapping remote from these critical sites. Prospective studies comparing multielectrode cases with point-by-point strategies may be insightful. As we continue along this road to higher resolution, we hope to be guided by thoughtful mechanistic investigation that can be translated to clinical practice, like the work presented by Tschabrunn et al 14 in this issue.
